Kailera Therapeutics (KLRA) Short Interest
Nasdaq • KLRA • US4829311020
As of Oct 27, 2026, ORTEX estimated 14.2% of free float sold short, 6.3 days to cover, cost to borrow 0.93%. Sign up for live short interest data.
Nasdaq • KLRA • US4829311020
As of Oct 27, 2026, ORTEX estimated 14.2% of free float sold short, 6.3 days to cover, cost to borrow 0.93%. Sign up for live short interest data.
This page tracks how heavily Kailera Therapeutics (Nasdaq:KLRA) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Kailera Therapeutics (Nasdaq: KLRA) has a market capitalization of $1.85B. Last close $14.38 (as of 2026-11-11); 52-week range $9.76 to $28.23. ORTEX data as of 2026-10-27: short interest was 14.18% of free float, 6.3 days to cover and the average cost to borrow was 0.93%. Sign up for live short interest data.